ADAS Biotechnology
Molecular diagnostic services and research into novel immuno-diagnostics
The ADAS Biotechnology team comprises highly experienced scientists working from bespoke molecular biology labs in south Nottingham. Our biotechnology business is run as two distinct strands:
- Developing and delivering molecular diagnostic services for species identification
- Conducting research into novel immuno-diagnostics and therapeutics
We deliver innovative solutions to diagnostic issues for a range of clients through developing bespoke diagnostic tests for diseases, pathogens other biological markers and contaminants. Our scientists also develop methodology for routine testing or screening purposes.
Research into novel immuno-diagnostics and therapeutics
Current research interests
- Novel phage display methods for peptide/antibody isolation, based around next generation phage display techniques:
- Novel phage display library construction
- Epitope mapping of antibody based immune responses for the development of novel sero-diagnostics (infectious disease and autoantibodies)
- Reverse vaccinology approaches to vaccine antigen discovery
- Biomarker discovery
- Novel methods for antimicrobial peptide isolation
- Immunoassay development (ELISA, Western blot) for a range of analytes
- Prion diseases or transmissible spongiform encephalopathies (TSEs) of livestock (long standing research into the dissemination, environmental fate, strain typing, pre-mortem diagnostics and in-vitro replication of ruminant prions)
- Monoclonal antibody isolation
- Recombinant protein production
ADAS Bat genotyping
